Peter M. Strumph, WG’95 - Alumni News

Back at a start-up. A few years ago, I co-founded Amygdala Neurosciences, Inc. We acquired an asset from Gilead Sciences which we are now developing to treat substance use disorders. We are starting Phase 2 studies for smoking cessation and opioid, alcohol, and cocaine use disorders.

Suzanne and I still live in San Francisco and, with our youngest off to college in the fall, are looking forward to being empty nesters.

 

Contact Peter at:
pstrumph@amygns.com

Learn more.